DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bauerschs RM, Lensing AWA, Prins MH. et al.
Rivaroxaban versus enoxaparin/vit-amin K antagonist therapy in patients with venous thromboembolism and renal impairment.
Thrombosis Journal 2014;
12: 25. Doi: 10.1186/1477-9560-12-25.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.